| Year |
Citation |
Score |
| 2016 |
Beckerman R, Yoh K, Mattia-Sansobrino M, Zupnick A, Laptenko O, Karni-Schmidt O, Ahn J, Byeon IJ, Keezer S, Prives C. Lysines in the tetramerization domain of p53 selectively modulate G1 arrest. Cell Cycle (Georgetown, Tex.). 1-14. PMID 27210019 DOI: 10.1080/15384101.2016.1170270 |
0.718 |
|
| 2016 |
Karni-Schmidt O, Lokshin M, Prives C. The Roles of MDM2 and MDMX in Cancer. Annual Review of Pathology. PMID 27022975 DOI: 10.1146/Annurev-Pathol-012414-040349 |
0.726 |
|
| 2015 |
Gaya JM, López-Martínez JM, Karni-Schmidt O, Bonal DM, Algaba F, Palou J, Villavicencio H, Benson MC, Cordon-Cardo C, Castillo-Martin M. ΔNp63 expression is a protective factor of progression in clinical high grade T1 bladder cancer. The Journal of Urology. 193: 1144-50. PMID 25444981 DOI: 10.1016/J.Juro.2014.10.098 |
0.358 |
|
| 2012 |
Gaya JM, Castillo-Martin M, Lopez-Martinez JM, Karni-Schmidt O, Gladoun N, Algaba F, Palou J, Villavicencio H, Benson MC, Cordon-Cardo C. 385 DELTAN P63 (ΔNP63) EXPRESSION AS A PROGNOSTIC FACTOR OF PROGRESSION IN CLINICAL HGT1 BLADDER CANCER Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.449 |
0.436 |
|
| 2011 |
Karni-Schmidt O, Castillo-Martin M, Shen TH, HuaiShen T, Gladoun N, Domingo-Domenech J, Sanchez-Carbayo M, Li Y, Lowe S, Prives C, Cordon-Cardo C. Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression. The American Journal of Pathology. 178: 1350-60. PMID 21356385 DOI: 10.1016/J.Ajpath.2010.11.061 |
0.689 |
|
| 2010 |
Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C. Molecular pathways of urothelial development and bladder tumorigenesis. Urologic Oncology. 28: 401-8. PMID 20610278 DOI: 10.1016/J.Urolonc.2009.04.019 |
0.438 |
|
| 2008 |
Karni-Schmidt O, Zupnick A, Castillo M, Ahmed A, Matos T, Bouvet P, Cordon-Cardo C, Prives C. p53 is localized to a sub-nucleolar compartment after proteasomal inhibition in an energy-dependent manner. Journal of Cell Science. 121: 4098-105. PMID 19033390 DOI: 10.1242/Jcs.030098 |
0.784 |
|
| 2007 |
Karni-Schmidt O, Friedler A, Zupnick A, McKinney K, Mattia M, Beckerman R, Bouvet P, Sheetz M, Fersht A, Prives C. Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus. Oncogene. 26: 3878-91. PMID 17237827 DOI: 10.1038/Sj.Onc.1210162 |
0.527 |
|
| 2003 |
Poyurovsky MV, Jacq X, Ma C, Karni-Schmidt O, Parker PJ, Chalfie M, Manley JL, Prives C. Nucleotide binding by the Mdm2 RING domain facilitates Arf-independent Mdm2 nucleolar localization. Molecular Cell. 12: 875-87. PMID 14580339 DOI: 10.1016/S1097-2765(03)00400-3 |
0.746 |
|
| 2001 |
Gottifredi V, Karni-Schmidt O, Shieh SS, Prives C. p53 down-regulates CHK1 through p21 and the retinoblastoma protein. Molecular and Cellular Biology. 21: 1066-76. PMID 11158294 DOI: 10.1128/Mcb.21.4.1066-1076.2001 |
0.785 |
|
| Show low-probability matches. |